Skip to Main Content

WASHINGTON — Senate Democrats are vetting a new, tweaked version of a drug pricing package as they hurtle toward a September deadline to pass any major reforms.

It’s by no means certain that Congress will pass prescription drug pricing reform as part of a broader domestic policy package being hammered out between Senate Majority Leader Chuck Schumer and moderate Sen. Joe Manchin (D-W.V.), but this week, the chances are looking better than ever.


Negotiations have come a long way — last October, the White House claimed the Democratic chasm on drug pricing policy was just too hard to bridge. Now, it’s the most solid plank of a potential deal that both Schumer and Manchin agree on. Drug pricing reform is enormously politically popular, and also would save the federal government money.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.